Evidence
Indian J Gastroenterol. 2024 Feb 17. doi: 10.1007/s12664-023-01512-y. Online ahead of print.
NO ABSTRACT
PMID:38367161 | DOI:10.1007/s12664-023-01512-y
Add to Google Keep
Estimated reading time: 1 minute(s)
Latest: Psychiatryai.com #RAISR4D
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Changing pattern of etiology of chronic liver disease in India: Alcohol and non-alcoholic fatty liver disease
🌐 90 Days
VR Related Evidence Matrix
- Critical care management of acute liver failure
- Epidemiological characteristics of inpatients with liver failure at the Beijing You'an Hospital from 2012 to 2021
- Occult liver disease: a multinational perspective
- Therapeutic potential of oleanolic acid in liver diseases
- Liver Transplantation in Chronic Liver Disease and Acute on Chronic Liver Failure- Indication, Timing and Practices
- Liver Transplantation in Chronic Liver Disease and Acute on Chronic Liver Failure- Indication, Timing and Practices
- Increased Risk of Colorectal Adenomas with Metabolic-Associated Fatty Liver Disease Components
- Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation
- Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation
- Spatial genomics: mapping human steatotic liver disease
- Independent Associations of Aortic Calcification with Cirrhosis and Liver Related Mortality in Veterans with Chronic Liver Disease
- Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease
- Preventive hepatology at AIIMS Rishikesh: Delivering comprehensive and integrated care for liver diseases in Northern state of India
- Prevalence and impact on the outcome of myosteatosis in patients with cirrhosis: a systematic review and meta-analysis
- Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12
- Sirt6 ablation in the liver causes fatty liver that increases cancer risky by upregulating Serpina12
- Research progress in the regulation of pathogenesis and the transformation of chronic liver disease by short-chain fatty acids
- Muscle strength and non-alcoholic fatty liver disease/metabolic-associated fatty liver disease
- What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?
- What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?
- Diabetes Mellitus among Patients with Non-alcoholic Fatty Liver Disease Visiting the Outpatient Department of Internal Medicine in a Tertiary Care Centre
- Changing trends in the etiology of liver transplantation in Turkiye: A multicenter study
- The Global Epidemic of Metabolic Fatty Liver Disease
- Mass spectrometry imaging-based metabolomics highlights spatial metabolic alterations in three types of liver injuries
- Ultrasonographic findings of metabolic dysfunction-associated fatty liver disease: A comparative study with non-alcoholic fatty liver disease and clinical characteristics
- Patients undergoing liver resection for non-alcoholic fatty liver disease-related hepatocellular carcinoma and those for viral hepatitis-related hepatocellular carcinoma have similar survival outcomes
- Targeted platelet with hydrogen peroxide responsive behavior for non-alcoholic steatohepatitis detection
- Chronic liver disease and management with silymarin: an introductory review of a clinical case collection
- Targeting metabolic-associated fatty liver disease in diabetic kidney disease: A call to action
- COVID-19 in Individuals with Chronic Liver Diseases
- Fecal microbiota transplantation for treatment of non-alcoholic fatty liver disease: Mechanism, clinical evidence, and prospect
- Iron metabolism and ferroptosis in Non-alcoholic fatty liver disease: what is our next step?
- Changes in the etiology of liver cirrhosis and the corresponding management strategies
- Aspirin for Non Alcoholic Fatty Liver Disease: Promising but Inconclusive - A Letter to the editor
- The Impact of Non-alcohol Fatty Liver Disease on Bone Mineral Density is Mediated by Sclerostin by Mendelian Randomization Study
- Beneficial Effects of Dietary Flaxseed on Non-Alcoholic Fatty Liver Disease
- The double roles of T cell-mediated immune response in the progression of MASLD
- SHMT2 reduces fatty liver but is necessary for liver inflammation and fibrosis in mice
- SHMT2 reduces fatty liver but is necessary for liver inflammation and fibrosis in mice
- Predictors and Outcomes of Post-transjugular Intrahepatic Portosystemic Shunt Liver Failure in Patients with Cirrhosis
- Compare the Combined Diagnostic Accuracy of Transient Elastography and Visual Liver Score in Assessing Non-Alcoholic Fatty Liver Disease (NAFLD) and Compare it with Liver Biopsy in Morbidly Obese Patients Undergoing Bariatric Surgery: An…
- Dietary pattern associated with non-alcoholic fatty liver disease (NAFLD) in non-diabetic adult patients: A case control study
- Dietary pattern associated with non-alcoholic fatty liver disease (NAFLD) in non-diabetic adult patients: A case control study
- Increasing the efficiency of hypolipidemic therapy with the combined use of quercetin in patients with non-alcoholic fatty liver disease on the background of the metabolic syndrome
- Mitochondrial dysfunction: A promising therapeutic target for liver diseases
- Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead
- Lipid sensing nuclear receptors involved in the pathogenesis of fatty liver disease
- Adipose-derived extracellular vesicles - a novel cross-talk mechanism in insulin resistance, non-alcoholic fatty liver disease, and polycystic ovary syndrome
- Exploring the interplay of gut microbiota, inflammation, and LDL-cholesterol: a multiomics Mendelian randomization analysis of their causal relationship in acute pancreatitis and non-alcoholic fatty liver disease
- Role of Angiotensin II in Non-Alcoholic Steatosis Development
- Comparison of size of the liver between patients with non-alcoholic fatty liver disease and healthy controls
- MAFLD as part of systemic metabolic dysregulation
- MAFLD as part of systemic metabolic dysregulation
- Plastic compounds and liver diseases: Whether bisphenol A is the only culprit
- Alcohol Drinking Impacts on Adiposity and Steatotic Liver Disease: Concurrent Effects on Metabolic Pathways and Cardiovascular Risks
- Dysregulation of RNA splicing in early non-alcoholic fatty liver disease through hepatocellular carcinoma
- Incretin-based investigational therapies for the treatment of MASLD/MASH
- Role of the angiopoietin-like protein family in the progression of NAFLD
- Evaluation of the role of body mass index (BMI) in the association between dietary inflammatory index and non-alcoholic fatty liver diseases: a letter to editor
- Glycyrrhizin and the Related Preparations: An Inspiring Resource for the Treatment of Liver Diseases
- Scientific commentary on: "Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer's disease and primary tauopathies"
- The Impact of Probiotic Bifidobacterium on Liver Diseases and the Microbiota
- Natural compounds proposed for the management of non-alcoholic fatty liver disease
- LncRNA HOTAIR accelerates free fatty acid-induced inflammatory response in HepG2 cells by recruiting SRSF1 to stabilize MLXIPL mRNA
Evidence Blueprint
Changing pattern of etiology of chronic liver disease in India: Alcohol and non-alcoholic fatty liver disease
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Changing pattern of etiology of chronic liver disease in India: Alcohol and non-alcoholic fatty liver disease
🌐 365 Days
VR Related Evidence Matrix
- Mean platelet volume for differentiating non-alcoholic fatty liver disease from non-alcoholic steatohepatitis: Is it ready for prime time?
- Diagnostic performance of non-invasive liver fibrosis risk scores in biopsy-proven non-alcoholic fatty liver disease patients in India
- Multi-center prospective survey of hepatocellular carcinoma in Kerala: More than 1,200 cases
- Association between hepatic steatosis and lipoprotein(a) levels in non-alcoholic patients: A systematic review
- Significant gut microbiota related to patterns of drinking and alcohol relapse in patients with alcoholic hepatitis undergoing stool transplant or corticosteroid therapy
- Is mean platelet volume a simple marker of non-alcoholic fatty liver disease?
- Simple bedside tests of muscle strength and function correlate with computed tomography-skeletal muscle index for assessment of sarcopenia in cirrhosis
- Critical care management of acute liver failure
- A study of genetic variants, genetic risk score and DNA methylation of PNPLA3 and TM6SF2 in alcohol liver cirrhosis
- Effect of the nomenclature of non-alcoholic fatty liver disease on diagnosis and treatment of fatty liver disease concomitant with other liver diseases
- Genetic polymorphisms in phase II metabolizing enzymes in alcoholic and idiopathic chronic pancreatitis: Indian scenario
- Screening, Diagnosis, and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD): Application of Society Guidelines to Clinical Practice
- Incidence, prevalence and mortality of chronic liver diseases in Sweden between 2005 and 2019
- Epidemiological characteristics of inpatients with liver failure at the Beijing You'an Hospital from 2012 to 2021
- Hepatocellular carcinoma surveillance - utilization, barriers and the impact of changing aetiology
- Comprehensive analysis of epigenetic and epitranscriptomic genes' expression in human NAFLD
- Enhanced non-alcoholic fatty liver detection: Computed tomography scan image analysis and noise reduction with morphological dilation
- How non-alcoholic fatty liver disease and cirrhosis affect the heart
- Occult liver disease: a multinational perspective
- Impact of Endoscopic Sleeve Gastroplasty in Non-alcoholic Fatty Liver Disease: a Systematic Review and Meta-analysis
- Non-alcoholic fatty liver disease in patients with type 2 diabetes: diagnostic and therapeutic considerations
- Using race as a social construct when looking at differences in racial associations between non-alcoholic fatty liver disease and type 2 diabetes
- Reply to Letter to the Editor regarding "Impact of Endoscopic Sleeve Gastroplasty in Non-alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis"
- Using race as a social construct when looking at differences in racial associations between non‑alcoholic fatty liver disease and type 2 diabetes. Reply to Rollin FG, Washington C, Fluker S-A [letter]
- Multiple Dimensions of using Mesenchymal Stem Cells for Treating Liver Diseases: From Bench to Beside
- Immunology of gut microbiome and liver in non-alcoholic fatty liver disease (NAFLD): mechanisms, bacteria, and novel therapeutic targets
- N6-methyladenosine RNA methylation in liver diseases: from mechanism to treatment
- Current understanding and future perspectives on the impact of changing NAFLD to MAFLD on global epidemiology and clinical outcomes
- Medium- and long-chain triglyceride propofol activates PI3K/AKT pathway and inhibits non-alcoholic fatty liver disease by inhibiting lipid accumulation
- Non-alcoholic fatty liver disease and periodontal disease: A systematic review and meta-analysis of cross-sectional studies
- Sarcopenia in chronic liver diseases
- The relationship between alcohol consumption and chronic kidney disease in patients with nonalcoholic fatty liver disease
- Towards precision medicine in non-alcoholic fatty liver disease
- Therapeutic potential of oleanolic acid in liver diseases
- Liver Transplantation in Chronic Liver Disease and Acute on Chronic Liver Failure- Indication, Timing and Practices
- Liver Transplantation in Chronic Liver Disease and Acute on Chronic Liver Failure- Indication, Timing and Practices
- Biomarkers of liver diseases
- Increased Risk of Colorectal Adenomas with Metabolic-Associated Fatty Liver Disease Components
- Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation
- Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation
- Liver health and the interplay between obesity, alcohol and bariatric surgery
- Spatial genomics: mapping human steatotic liver disease
- Impacts of Non-alcoholic Fatty Liver Disease on Acute Coronary Syndrome: Evidence and Controversies
- Non-Alcoholic Fatty Liver Disease as an Emerging Risk Factor for Heart Failure
- Alcohol as a health risk: new recommendations for dealing with alcohol
- The future of incretins in the treatment of obesity and non-alcoholic fatty liver disease
- Serum Ferritin and Non-alcoholic Fatty Liver Disease: A Meta-analysis and Systematic Review
- Serum interleukin-6 level predicts the prognosis for patients with alcohol-related acute-on-chronic liver failure
- Exercise in the Management of Metabolic-Associated Fatty Liver Disease (MAFLD) in Adults: A Position Statement from Exercise and Sport Science Australia
- Independent Associations of Aortic Calcification with Cirrhosis and Liver Related Mortality in Veterans with Chronic Liver Disease
- Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease
- Preventive hepatology at AIIMS Rishikesh: Delivering comprehensive and integrated care for liver diseases in Northern state of India
- The significance of omega-3 fatty acids in the treatment of non-alcoholic fatty liver disease
- The role of Sirtuin 2 in liver - An extensive and complex biological process
- Fatty liver disease's renaming impacts on drug clinical trials
- Prevalence of portal vein thrombosis in non-alcoholic fatty liver disease: a meta-analysis of observational studies
- Seroprevalence of hepatitis E virus in patients with chronic liver disease
- Glp-1 Receptor Agonists Regulate the Progression of Diabetes Mellitus Complicated with Fatty Liver by Down-regulating the Expression of Genes Related to Lipid Metabolism
- Glp-1 Receptor Agonists Regulate the Progression of Diabetes Mellitus Complicated with Fatty Liver by Down-regulating the Expression of Genes Related to Lipid Metabolism
- Prevalence and impact on the outcome of myosteatosis in patients with cirrhosis: a systematic review and meta-analysis
- Mulberry fruit repairs alcoholic liver injury by modulating lipid metabolism and the expression of miR-155 and PPARα in rats
- Liver-derived extracellular vesicles improve whole-body glycaemic control via inter-organ communication
- Liver Transplantation Outcomes of HBV-, HCV-, and Alcohol-induced Hepatocellular Carcinoma in the United States: Analysis of National Inpatient Samples
- Metabolic Health and Disease: A Role of Osteokines?